Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - MEI Pharma, Inc. | d58841dex321.htm |
| EX-31.2 - EX-31.2 - MEI Pharma, Inc. | d58841dex312.htm |
| EX-31.1 - EX-31.1 - MEI Pharma, Inc. | d58841dex311.htm |
| EX-10.18 - EX-10.18 - MEI Pharma, Inc. | d58841dex1018.htm |
| EX-4.3 - EX-4.3 - MEI Pharma, Inc. | d58841dex43.htm |
| 10-K - FORM 10-K - MEI Pharma, Inc. | d58841d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
MEI Pharma, Inc.
San Diego, CA
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-238056, 333-225465, 333-186070, 333-184011, 333-174789, 333-146453, and 333-136440) and Form S-8 (File Nos. 333-229554, 333-216103, 333-213278, 333-201703, 333-179591, 333-174790, 333-169719, and 333-156985) of MEI Pharma, Inc. (the “Company”) of our report dated September 9, 2020, relating to the financial statements, which appears in this Form 10-K.
/s/ BDO USA, LLP
San Diego, California
September 9, 2020